PEN — Penumbra, Inc. stock price, charts and financials

QT41Penumbra, Inc.

Penumbra, Inc. (NYSE: PEN) is a Healthcare company in the Medical - Devices industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
324.22
+1.20+0.37%
PENQT41Penumbra, Inc.·NYSE
324.22+0.37%

Latest SEC Filings

Form category
Filing DateFormDescriptionFilingDocument
Jul 30, 202610-QQuarterly report
Jul 30, 20268-KCurrent report
Jun 22, 20268-KCurrent report
May 29, 2026SDSpecialized disclosure report
May 21, 20264Statement of changes in beneficial ownership
May 07, 2026425Prospectus / business-combination communication
May 07, 20268-KCurrent report
May 06, 202610-QQuarterly report
May 06, 20268-KCurrent report
Apr 30, 2026SC 13GBeneficial ownership statement (passive)
Apr 29, 2026DEFA14AAdditional proxy soliciting materials
Apr 29, 2026DEF 14ADefinitive proxy statement
Apr 29, 2026ARSAnnual report to shareholders
Apr 23, 2026425Prospectus / business-combination communication
Apr 22, 2026425Prospectus / business-combination communication
Apr 17, 2026425Prospectus / business-combination communication
Apr 06, 20264Statement of changes in beneficial ownership
Apr 02, 2026144Notice of proposed sale of restricted securities
Apr 01, 2026DEFM14ADefinitive proxy statement (merger)
Mar 27, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Mar 17, 20264Statement of changes in beneficial ownership
Mar 17, 20264Statement of changes in beneficial ownership
Mar 17, 20264Statement of changes in beneficial ownership
Mar 17, 20264Statement of changes in beneficial ownership
Mar 04, 20264Statement of changes in beneficial ownership